Skip to content

Need for dialysis access procedures among patients receiving peritoneal dialysis and hemodialysis

Among patients who choose between peritoneal dialysis and hemodialysis, does the initial access type influence access related adverse events?

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12610000674033
Enrollment
412
Registered
2010-08-17
Start date
2007-07-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The primary aim of this study is to compare the risk of access-related procedures between peritoneal dialysis and hemodialysis Procedures to maintain access to the peritoneum or the bloodstream are important measures of safety because they are caused by complications that “require intervention in order to prevent permanent impairment or damage”. This usually meets the definition of a serious adverse event because loss of access is a life-threatening event for a chronic dialysis patient.

Interventions

Incident patients with end stage renal disease (ESRD) who are eligible for both are offerred peritoneal dialysis (PD) or hemodialysis (HD). The PD group has access to up to two nursing visits a day to assisted with PD (primarily cycler PD). Peritoneal dialysis is treatment by continuous ambulatory PD or automated PD. Hemodialysis is intermittent treatments usually three times per week but patients could receive more treatments per week if clinically indicated. Observation was from the star

Incident patients with end stage renal disease (ESRD) who are eligible for both are offerred peritoneal dialysis (PD) or hemodialysis (HD). The PD group has access to up to two nursing visits a day to assisted with PD (primarily cycler PD). Peritoneal dialysis is treatment by continuous ambulatory PD or automated PD. Hemodialysis is intermittent treatments usually three times per week but patients could receive more treatments per week if clinically indicated. Observation was from the start of dialysis to the end of dialysis (transplant, death) or lost to follow-up or end of the study.

Sponsors

Canadian Institutes of Health Research
Lead SponsorGovernment body

Eligibility

Sex/Gender
All
Age
18 Years to 120 Years
Healthy volunteers
No

Inclusion criteria

1) Written or verbal diagnosis of stage 5 chronic kidney disease or end stage renal disease by nephrologist initiated dialysis therapy 3) Eligible for both peritoneal dialysis and hemodialysis. 3) Lives in region and residence where home care assistance for peritoneal dialysis is available.

Exclusion criteria

1) Determined to be a prevalent (not incident) dialysis patient defined as having received dialysis for greater than three months any time prior to assessment or having received a previous kidney transplant 2) Died, withdrew from dialysis, or moved out of region prior to completing multidisciplinary assessment 3) Recovered renal function and discontinued dialysis 4) Refused to participate in a complete multidisciplinary assessment for modality eligibility

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026